Cognition Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Cognition Therapeutics

08/08/2023 14:33

* Cognition Therapeutics Inc  CGTX.OQ  reported a quarterly
adjusted loss of 16 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cognition Therapeutics Inc's reported EPS for the quarter
was a
loss of 16 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cognition Therapeutics Inc shares had fallen by 5.2% this
quarter and lost 17.4% so far this year.
    * The company reported a quarterly loss of $4.73 million.
    * Wall Street's median 12-month price target for Cognition
Therapeutics Inc is $8.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.19          -0.16          Beat
 Mar. 31 2023      -0.18          -0.21          Missed
 Dec. 31 2022      -0.22          -0.20          Beat
 Sep. 30 2022      -0.38          -0.29          Beat